Haematology Practice Review Issue 62
Lymphoma & Leukaemia Watch 45 – MRD in CLL… what is it and does it matter?
Study Review – GLOW Study update: Long-term efficacy and safety of ibrutinib-venetoclax in first-line CLL
Lymphoma & Leukaemia Research Review, Issue 96
Product Review – Brexucabtagene autoleucel for treating adults with relapsed or refractory B-cell precursor ALL
Lymphoma & Leukaemia Practice Review Issue 2
Haematology Watch 35 – Management of TTP after rituximab failure/intolerance
